MGNX

MacroGenics Inc (MGNX)

US
$ 3.240.93%

Price Chart

Key Statistics

Market Cap
$ 97.16M
P/E Ratio
0.00
Revenue (TTM)
$ 154.05M
Volume
393.1K
52W High
$ 5.77
52W Low
$ 0.99
Dividend Yield
0.00%
Beta
1.63

Technicals

50-Day MA
1.4897
200-Day MA
2.5301
52 Week High
5.77
52 Week Low
0.9897

About MGNX

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.

Employees
341
Headquarters
Rockville, MD
CEO
Dr. Scott Koenig M.D., Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96